CGS 27023A

CAS No. 161314-82-5

CGS 27023A ( CGS-27023A; CGS 27023A; MMI270B )

Catalog No. M17341 CAS No. 161314-82-5

CGS 27023A is a non-peptidic, potent, and orally active stromelysin inhibitor.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 52 In Stock
5MG 77 In Stock
10MG 107 In Stock
25MG 261 In Stock
50MG 379 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CGS 27023A
  • Note
    Research use only, not for human use.
  • Brief Description
    CGS 27023A is a non-peptidic, potent, and orally active stromelysin inhibitor.
  • Description
    CGS-27023A is a novel matrix metalloproteinase inhibitor.
  • Synonyms
    CGS-27023A; CGS 27023A; MMI270B
  • Pathway
    Tyrosine Kinase
  • Target
    FLT3
  • Recptor
    MMP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    161314-82-5
  • Formula Weight
    429.92
  • Molecular Formula
    C18H24ClN3O5S
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    C(=O)([C@@H](C(C)C)N(Cc1cnccc1)S(=O)(=O)c1ccc(cc1)OC)NO.Cl
  • Chemical Name
    (2R)-N-hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. MacPherson LJ, et al. J Med Chem. 1997 Aug 1;40(16):2525-32.
molnova catalog
related products
  • Quizartinib hydrochl...

    Quizartinib (AC220) is a potent, selective, second-generation FLT3 inhibitor with Kd of 1.6 nM.

  • KIN1148

    KIN1148 is a novel small-molecule adjuvant that acts through the RIG-I pathway and IRF-3 transcription factor to stimulate inN/Ate immunity and protection following viral infection.

  • CGS 27023A

    CGS 27023A is a non-peptidic, potent, and orally active stromelysin inhibitor.